Bindraban, Anita N <br/><br/>
Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.  [electronic resource] 

 -  International journal of clinical pharmacy  Oct 2018 
 - 1372-1379 p.  digital 
<br/><br/> Publication Type: Journal Article; Validation Study 
<br/><br/><label>ISSN: </label>2210-7711 
<br/><br/><label>Standard No.: </label>10.1007/s11096-018-0692-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Decision Support Systems, Clinical<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Electrocardiography<br/>Female<br/>Humans<br/>Logistic Models<br/>Long QT Syndrome--chemically induced<br/>Male<br/>Middle Aged<br/>Models, Statistical<br/>Netherlands<br/>ROC Curve<br/>Retrospective Studies<br/>Risk Factors<br/>Sensitivity and Specificity